1
|
Zheng S and Shanrong C: Colorectal cancer
epidemiology and prevention study in China. Chin Ger J Clin Oncol.
2:72–75. 2003. View Article : Google Scholar
|
2
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
3
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
4
|
Hynes RO: Integrins: bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hood JD and Cheresh DA: Role of integrins
in cell invasion and migration. Nat Rev Cancer. 2:91–100. 2002.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Melker AA and Sonnenberg A: Integrins:
alternative splicing as a mechanism to regulate ligand binding and
integrin signaling events. Bioessays. 21:499–509. 1999. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gilcrease MZ: Integrin signaling in
epithelial cells. Cancer Lett. 247:1–25. 2007. View Article : Google Scholar
|
8
|
Felding-Habermann B: Integrin adhesion
receptors in tumor metastasis. Clin Exp Metastasis. 20:203–213.
2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Li N, Zhang Y, Naylor MJ, Schatzmann F,
Maurer F, Wintermantel T, Schuetz G, Mueller U, Streuli CH and
Hynes NE: β integrins regulates mammary proliferation and maintain
the integrity of mammary alveoli. EMBO J. 24:1942–1953. 2005.
|
10
|
Arao S, Masumoto A and Otsuki M: β1
integrins play an essential role in adhesion and invasion of
pancreatic carcinoma cells. Pancreas. 20:129–137. 2000.
|
11
|
Aumailley M, Pesch M, Tunggal L, Gaill F
and Fässler R: Altered synthesis of laminin 1 and absence of
basement membrane component deposition in β1 integrin deficient
embryoid bodies. J Cell Sci. 113:259–268. 2001.PubMed/NCBI
|
12
|
Stroeke PJ, van Rijthoven EA, Boer E,
Geerts D and Roos E: Cytoplasmic domain mutants of β1 integrin,
expressed in β1-knockout lymphoma cells, have distinct effects on
adhesion, invasion and metastasis. Oncogene. 19:1232–1238.
2000.
|
13
|
Brakebusch C and Fassler R: β1 integrin
function in vivo: adhesion, migration and more. Cancer
Metastasis Rev. 24:403–411. 2005.
|
14
|
Wang W, Goswami S, Lapidus K, Wells AL,
Wyckoff JB, Sahai E, Singer RH, Segall JE and Condeelis JS:
Identification and testing of a gene expression signature of
invasive carcinoma cells within primary mammary tumors. Cancer Res.
64:8585–8594. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yao ES, Zhang H, Chen YY, Lee B, Chew K,
Moore D and Park C: Increased β1 integrin is associated with
decreased survival in invasive breast cancer. Cancer Res.
67:659–664. 2007.
|
16
|
Wang D, Müller S, Amin AR, Huang D, Su L,
Hu Z, Rahman MA, Nannapaneni S, Koenig L, Chen Z, Tighiouart M,
Shin DM and Chen ZG: The pivotal role of integrin β1 in metastasis
of head and neck squamous cell carcinoma. Clin Cancer Res.
18:4589–4599. 2012.
|
17
|
Adachi M, Taki T, Higashiyama M, Kohno N,
Inufusa H and Miyake M: Significance of integrin α5 gene
expression as a prognostic factor in node-negative non-small cell
lung cancer. Clin Cancer Res. 6:96–101. 2000.
|
18
|
Ahmed N, Riley C, Rice G and Quinn M: Role
of integrin receptors for fibronectin, collagen and laminin in the
regulation of ovarian carcinoma functions in response to a matrix
microenvironment. Clin Exp Metastasis. 22:391–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Park CC, Zhang H, Pallavicini M, Gray JW,
Baehner F, Park CJ and Bissell MJ: β1 integrin inhibitory antibody
induces apoptosis of breast cancer cells, inhibits growth and
distinguishes malignant from normal phenotype in three dimensional
cultures and in vivo. Cancer Res. 66:1526–1535. 2006.
|
20
|
Cory S and Adams JM: The Bcl2 family:
regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Bakhshi A, Jensen JP, Goldman P, Wright
JJ, McBride OW, Epstein AL and Korsmeyer SJ: Cloning the
chromosomal breakpoint of t(14;18) human lymphomas: clustering
around JH on chromosome 14 and near a transcriptional unit on 18.
Cell. 41:899–906. 1985. View Article : Google Scholar : PubMed/NCBI
|
22
|
Puthalakath H and Strasser A: Keeping
killers on a tight leash: transcriptional and post-translational
control of the pro-apoptotic activity of BH3-only proteins
(Review). Cell Death Differ. 9:505–512. 2002. View Article : Google Scholar
|
23
|
Thome M and Tschopp J: Regulation of
lymphocyte proliferation and death by FLIP. Nat Rev Immunol.
1:50–58. 2001. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Sherr CJ: G1 phase progression: Cycling on
cue. Cell. 79:551–555. 1994. View Article : Google Scholar : PubMed/NCBI
|
25
|
Huang S, Chen CS and Ingber DE: Control of
cyclin D1, p27Kip1, and cell cycle progression in human
capillary endothelial cells by cell shape and cytoskeletal tension.
Mol Biol Cell. 9:3179–3193. 1998.
|